Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical "
World News
– Pharmaceutical company Perrigo has yet to be sold and already major business publications are speculating on what its sale will mean to the TASE....
Money
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ ...
Business
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical...
VC, Investments
– – Last year, Rami Levy joined BTI, the group of businesspeople that supports peace with the Palestinians for the sake of the economy....
IPOs
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
Business
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
Business
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
Leadership & A-List
– – Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He...
StartUps
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
Business
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...